Showing results (271-280 of 397) with videos related to
Sort By:
Pageof 40
Gynecologic Oncology|August 6, 2000
Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcomaD M Kushner, K D Webster, J L Belinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancerB Reichman, M Markman, T Hakes, et al.Obstetrics and Gynecology|June 1, 1988
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinomaS C Rubin, E D Dulaney, M Markman, et al.Gynecologic Oncology|November 5, 1997
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-upF Shapiro, J Schneider, M Markman, et al.Gynecologic Oncology|August 12, 1998
Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancerM Markman, S M Lichtman, H Homesley, et al.Gynecologic Oncology|December 22, 1999
Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trialM Markman, J A Blessing, K DeGeest, et al.JACC. Case Reports|July 2, 2026
Transhepatic Access for Pulsed Field Ablation of Atrial Fibrillation Using a Dual-Energy Lattice-Tip CatheterMichael J Litt, Mohammad M Gad, Amir Heravi, et al.Gynecologic Oncology|July 1, 1999
Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group studyJ S Berek, M Markman, J A Blessing, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapyS B Howell, S Zimm, M Markman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studiesV W Rusch, D Niedzwiecki, Y Tao, et al.Pageof 40